Cutera Inc (CUTR) 11.09 $CUTR Cutera reports 1Q

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cutera Inc (CUTR) 11.09 $CUTR

Cutera reports 1Q loss
Automated Insights - Mon May 02, 4:21PM CDT
BRISBANE, Calif. (AP) _ Cutera Inc. (CUTR) on Monday reported a loss of $2.1 million in its first quarter.
CUTR: 11.09 (+0.09)

Cutera Reports First Quarter 2016 Results
GlobeNewswire - Mon May 02, 3:02PM CDT
-- Revenue Increased 18% to $22.4 million
CUTR: 11.09 (+0.09)

Cutera, Inc. to Announce Results for the First Quarter Ended March 31, 2016
GlobeNewswire - Tue Apr 19, 4:00PM CDT
Cutera, Inc. (Nasdaq:CUTR), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, will announce results for the first quarter ended March 31, 2016 on Monday, May 2, 2016, after market close. The Company will also host a conference call to discuss these results with additional comments and details. Participating on the call will be Kevin Connors, President and Chief Executive Officer, and Ron Santilli, Executive Vice President and Chief Financial Officer.
CUTR: 11.09 (+0.09)

Cutera (CUTR) Sees Hammer Chart Pattern: Time to Buy?
Zacks Equity Research - Zacks Investment Research - Tue Mar 29, 9:19AM CDT
Cutera, Inc. (CUTR) has been struggling lately, but the selling pressure may be coming to an end soon
CUTR: 11.09 (+0.09)

Cutera (CUTR) Shows Strength: Stock Adds 5.2% in Session
Zacks Equity Research - Zacks Investment Research - Wed Feb 10, 7:30AM CST
Cutera, Inc. (CUTR) was a big mover last session, as the company saw its shares rise over 5% on the day.
ESIO: 6.03 (+0.21), CUTR: 11.09 (+0.09)

Cutera posts 4Q profit
Automated Insights - Mon Feb 08, 3:30PM CST
BRISBANE, Calif. (AP) _ Cutera Inc. (CUTR) on Monday reported fourth-quarter net income of $2.1 million, after reporting a loss in the same period a year earlier.
CUTR: 11.09 (+0.09)

Cutera Reports Fourth Quarter 2015 Results
GlobeNewswire - Mon Feb 08, 3:03PM CST
-- Sixth Consecutive Quarter of Double-Digit Revenue Growth
CUTR: 11.09 (+0.09)

17.2% Return Seen to Date on SmarTrend Cutera Call (CUTR)
Comtex SmarTrend(R) - Tue Feb 02, 5:18PM CST
SmarTrend identified a Downtrend for Cutera (NASDAQ:CUTR) on December 10th, 2015 at $12.94. In approximately 2 months, Cutera has returned 17.20% as of today's recent price of $10.71.
CUTR: 11.09 (+0.09)

How it All Plays Out - Free Research Reports on Hill International, Marinus Pharmaceuticals, Ampio Pharmaceuticals and Cutera
ACCESSWIRE - Fri Dec 18, 6:35AM CST
NEW YORK, NY / ACCESSWIRE / December 18, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Hill International Inc. (NYSE: HIL), Marinus Pharmaceuticals Inc. (NASDAQ: MRNS), Ampio Pharmaceuticals Inc. (NYSE: AMPE) and Cutera Inc. (NASDAQ: CUTR). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
HIL: 4.44 (+0.07), MRNS: 1.43 (-0.07), AMPE: 1.09 (-0.06), CUTR: 11.09 (+0.09)

Equities on the Move - Research on Guidance Software, Impac Mortgage, Cutera and Ducommun
ACCESSWIRE - Mon Nov 30, 7:05AM CST
NEW YORK, NY / ACCESSWIRE / November 30, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Guidance Software Inc. (NASDAQ: GUID), Impac Mortgage Holdings Inc. (NYSE: IMH), Cutera Inc. (NASDAQ: CUTR) and Ducommun Inc. (NYSE: DCO). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
GUID: 6.06 (+0.15), DCO: 19.78 (+0.29), IMH: 17.67 (+0.49), CUTR: 11.09 (+0.09)

Why Cutera (CUTR) Stock Might be a Great Pick
Zacks Equity Research - Zacks Investment Research - Fri Nov 20, 7:31AM CST
Cutera is seeing solid earnings estimate revision activity and is a great company from a Zacks Industry Rank perspective
CUTR: 11.09 (+0.09)

New Strong Buy Stocks for November 12th
Zacks Equity Research - Zacks Investment Research - Thu Nov 12, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday
CPK: 65.24 (+0.55), BCRH: 18.14 (unch), CB: 130.24 (+1.61), CUTR: 11.09 (+0.09), BLDR: 12.34 (+0.52)

Cutera to Participate in Upcoming Investor Conferences
GlobeNewswire - Mon Nov 09, 3:45PM CST
Cutera, Inc. (Nasdaq:CUTR), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, announced today that Kevin Connors, the Company's President and Chief Executive Officer, will be presenting at the Canaccord Genuity Medical Technology & Diagnostics Forum on Thursday, November 19 at 9:00a.m. EST in New York City.
CUTR: 11.09 (+0.09)

Cutera Reports Third Quarter 2015 Results
GlobeNewswire - Mon Nov 02, 3:02PM CST
Cutera, Inc. (NASDAQ:CUTR) ("Cutera" or the "Company", a leading provider of laser and energy-based aesthetic systems for practitioners worldwide, today reported financial results for the third quarter ended September 30, 2015.
CUTR: 11.09 (+0.09)

Cutera, Inc. to Announce Results for the Third Quarter Ended September 30, 2015
GlobeNewswire - Mon Oct 19, 8:23AM CDT
Cutera, Inc. (Nasdaq:CUTR), a leading provider of laser, light and other energy-based aesthetic systems for practitioners worldwide, will announce results for the third quarter ended September 30, 2015 on Monday, November 2, 2015, after market close. The Company will also host a conference call to discuss these results with additional comments and details. Participating on the call will be Kevin Connors, President and Chief Executive Officer, and Ron Santilli, Executive Vice President and Chief Financial Officer.
CUTR: 11.09 (+0.09)

Commit To Purchase Cutera At $15, Earn 17.9% Annualized Using Options
StockOptionsChannel.com - Thu Sep 10, 10:42AM CDT
Investors eyeing a purchase of Cutera Inc stock, but cautious about paying the going market price of $15.02/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in...
CUTR: 11.09 (+0.09)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Beta Bionics Faces Class Action Lawsuit Amid FDA Concerns

Updated Category News Views 252

Beta Bionics in the Legal Crosshairs When a company like Beta Bionics gets hauled into court, you know it's not just smoky mirrors and boardroom politics. The stakes are high right now, with investors lining up for a class-action lawsuit that zeroes in on a nasty bundle of allegations. This isn't just a blip on the radar. It's a seismic wave in the industry. Allegations...

Continue Reading
Joshua Davenport: Celebrating 25 Years in Healthcare

Updated Category News Views 113

25 Years Strong: Davenport's Journey in Healthcare Not every day you celebrate someone who's spent a quarter of a century in the trenches of healthcare. Joshua L. Davenport, RN, isn't just clocking years; he's built a legacy in emergency nursing and occupational health that speaks volumes about resilience and commitment to others. From Humble Beginnings to Health...

Continue Reading
SLM Faces Legal Scrutiny as Losses Mount Amid Pause

Updated Category News Views 115

SLM's Latest Troubles: Legal and Financial Impact Ah, student loans—not just a headache for borrowers but now for lenders too. SLM Corporation, that name we know all too well in the student debt circus, has hit a snag. They've paused most of their third-party recovery activities. Let's dig in: net charge-offs for SLM in the third quarter shot up to a hefty $90.4...

Continue Reading
DigitalXForce Booms with 514% Growth and Major Backing

Updated Category News Views 204

Massive Growth and Strategic Investment in DigitalXForce Now here’s a company that’s shaking things up—DigitalXForce. Right on the back of a staggering 514% growth, they’ve corralled a strategic investment from Arsenal Growth Equity. If you blink, you might miss just how fast they’re sprinting through the tech landscape. Institutional Support Backing the...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 87

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 46

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Chemours Faces Class Action Over Fraud Allegations

Updated Category News Views 239

Chemours and the Aftermarket Mirage When it rains, it pours, and for Chemours, the forecast isn't looking sunny. Investors are gearing up to slap Chemours Company (NYSE: CC) with a securities fraud class action. Why, you ask? Overstatement of aftermarket demand for refrigerants left investors high and dry after stock prices took an 18% nosedive. On August 4, 2026,...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 146

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
NEXT Properties Exchange Offers: The Full Breakdown

Updated Category News Views 109

What's the Deal with These Exchange Offers? You know, nothing says 'we're changing things up' like an exchange offer. So what did NEXT Properties do? Well, they laid down two offers for the books on their outstanding 6.950% and 6.390% senior notes, due in 2044 and 2050, respectively. These are getting swapped out for some fresh 7.731% senior sustainability-linked notes...

Continue Reading
Darden Faces Class Action Over Reimbursement Failures

Updated Category News Views 98

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Continue Reading

Top 5 Most Recently Viewed Articles

KuCoin Introduces Global Sell-to-Card for 41 Fiat Currencies

Updated Category News Views 169

KuCoin Unveils Improved Sell-to-Card Feature for Users KuCoin, a trusted name in the cryptocurrency arena, has announced an exciting enhancement to its Fast Trade platform. This upgrade includes the introduction of a global Sell-to-Card feature, which allows users to convert USDT into 41 different fiat currencies and seamlessly withdraw these funds to their Visa or...

Continue Reading
Helen Of Troy Surprises with Positive Earnings Amid Market Moves

Updated Category News Views 88

U.S. Markets Show Mixed Signals as Dow Surges The trading day started off with mixed results as the U.S. stock market revealed contrasting trends among its key indices. The Dow Jones Industrial Average notably climbed over 100 points, indicating strength in some segments of the market. Market Movements As the market opened, the Dow experienced an increase of 0.35%,...

Continue Reading
Exploring the Growth of $1000 Investment in Cencora Stock

Updated Category News Views 87

The Growth Journey of Cencora Investments Cencora (NYSE: COR) has showcased remarkable performance over the past five years, demonstrating its ability to grow even amidst market ups and downs. Its position in the market has been bolstered by an outstanding annual return rate of 23.07%, surpassing many of its competitors. With a current market capitalization of around...

Continue Reading
WORK Medical Innovates Through Strategic RWA Partnerships

Updated Category News Views 182

WORK Medical Ventures into RWA Tokenization WORK Medical Technology Group Ltd. is embarking on an exciting journey to integrate real-world asset (RWA) technology into its operations. This innovative approach aims to transform the company's existing product systems and embrace advancements in artificial intelligence (AI). Strategic Partnerships In its latest move, WORK...

Continue Reading
Carrier Global Corporation Announces Conference Participation

Updated Category News Views 189

Carrier Global Corporation at the Annual Morgan Stanley Laguna Conference Carrier Global Corporation (NYSE: CARR), a prominent name in intelligent climate and energy solutions, is set to make waves at the 13th Annual Morgan Stanley Laguna Conference. The event, taking place in a friendly atmosphere, will feature Carrier's Chairman and CEO, David Gitlin, along with Senior...

Continue Reading